Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
asthma
Biotech
Roche pens $1B deal for respiratory bispecific from China
Roche headed back to China to pen a licensing deal worth over $1 billion biobucks for a clinical-stage bispecific antibody for respiratory diseases.
James Waldron
Oct 30, 2025 5:04am
Areteia posts ph. 3 asthma win for oral rival to biologic drugs
Sep 16, 2025 9:20am
Enveda harvests another $150M to advance nature-inspired drugs
Sep 4, 2025 9:14am
Jasper warns of restructuring after dud drug derails trials
Jul 7, 2025 9:23am
Vaccine protects mice from allergic reactions for a year
Apr 17, 2025 1:04pm
Sanofi's hopes for $1.1B Kymab drug dented after ph. 2 asthma fail
Apr 15, 2025 7:34am